Biocon Limited (NSE:BIOCON)
India
· Delayed Price · Currency is INR 340.90
-4.65 (-1.35%)
Mar 28, 2025, 3:29 PM IST
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.05M INR
Profits / Employee
492.98K INR
Market Cap
408.95B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Biocon News
- 4 days ago - Kiran Mazumdar Shaw Compares Bengaluru To Ecuador's Well-Designed Streets: "Hang Your Head In Shame" - NDTV
- 7 days ago - Biocon stock in focus today: Biocon Pharma gets US FDA nod for norepinephrine injection - Business Upturn
- 21 days ago - Stocks to watch today, March 10: Sun Pharma, ONGC, JSW Steel, Biocon, Omaxe and more - Business Upturn
- 24 days ago - Stocks to watch today: TCS, IndiGo, BEL, Biocon, JSW Energy in Focus; Bajaj Finserv, Ola Electric, Go Fashion Decline on March 7, 2025 - Business Upturn
- 24 days ago - Stocks to Watch today: Kalpataru Projects, Bharat Electronics, Biocon, RVNL, Brigade, IndiGo, Power Grid in focus on March 7, 2025 - Business Upturn
- 26 days ago - Stocks to watch today: Power Grid, ONGC, Adani Wilmar, Biocon, Apollo Hospitals, JSW Energy among stocks in focus on March 5, 2025 - Business Upturn
- 27 days ago - Biocon Pharma secures US FDA approvals for Lenalidomide, Dasatinib, and Rivaroxaban tablets - Business Upturn
- 4 weeks ago - Pharma Stocks: Glenmark down 2.43%, Divi’s Lab slips 2.10%, Biocon drops 2.57%, Glaxo plunges 3.44%, Nifty down 1.22% - Business Upturn